MKI67 and neoplasm: Pathological and immunohistochemical examination of tumor samples indicated that PEG-MP9-aPDL1 and PEG-MP9 treatment led to significantly increased necrotic lesions, TUNEL-positive cells, and decreased Ki-67 positive cells, when compared to the vehicle control (Figure 6F, H).